Table 2.
Mean cardiac output measurementsa
| Baseline CO (L/min), n = 17 using both COTD and CCO | |
| PAC (COTD/CCO) | 5.6 ± 1.5 |
| LiDCO Plus | 5.4 ± 1.6 |
| PiCCO | 5.4 ± 1.5 |
| FloTrac/Vigileo | 6.1 ± 1.9 |
| Baseline CO (L/min), n = 10 using COTD | |
| COTD PAC | 6.0 ± 1.3 |
| LiDCO Plus | 5.9 ± 1.3 |
| PiCCO | 6.0 ± 1.3 |
| FloTrac/Vigileo | 6.9 ± 1.5 |
| Baseline CO (L/min), n = 7 using CCO | |
| CCO PAC | 4.8 ± 1.4 |
| LiDCO Plus | 4.5 ± 1.8 |
| PiCCO | 4.3 ± 1.5 |
| FloTrac/Vigileo | 4.8 ± 1.7 |
| Therapeutic interventions | Number |
| Vasodilator (any ∆ > 0.1 μg/kg/min in nitroprusside infusion) | 34 |
| Vasoconstrictor (any ∆ > 0.01 μg/kg/min in norepinephrine or phenylephrine infusion) | 8 |
| Volume challenge (any volume > 250 cc of PRBC, FFP, platelets or 0.9% saline given over < 30 min) | 8 |
| Inotrope (any ∆ > 0.01 μg/kg/min in epinephrine or > 1 μg/kg/min in dopamine or dobutamine infusion) | 10 |
| Combination of any two or more interventions simultaneously | 66 |
aData are presented as means ± SD, and for characteristics of the events, total number. PAC, pulmonary artery catheter; COTD/CCO, intermittent bolus/continuous cardiac output; ∆, change; PRBC, packed red blood cells; FFP, fresh frozen plasma.